SCHEDULE 13D/A//SEC Filing
Inozyme Pharma, Inc. SCHEDULE 13D/A
Accession 0000950170-25-111753
CIK 0001695076other
Filed
Aug 26, 8:00 PM ET
Accepted
Aug 27, 5:42 PM ET
Size
18.7 KB
Accession
0000950170-25-111753
Documents
Issuer
Pivotal bioVenture Partners Fund I, L.P.
CIK 0001695076
Entity typeother
IncorporatedCayman Islands
Related Parties
1- filerCIK 0001695076
Filing Metadata
- Form type
- SCHEDULE 13D/A
- Filed
- Aug 26, 8:00 PM ET
- Accepted
- Aug 27, 5:42 PM ET
- Size
- 18.7 KB